Cargando…

LKB1 inhibits proliferation, metastasis and angiogenesis of thyroid cancer by upregulating SIK1

Purpose: Liver kinase B1 (LKB1), also known as serine/threonine kinase 11, was considered as a tumor suppressor, which exhibited anti-cancer activity in a variety of cancers. However, the effect of LKB1 in thyroid cancer remains unclear. Methods: In the study, MTT assay, colony formation assay, flow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kou, Bo, Wang, Xin-Di, Sun, Xiao-Peng, Qi, Qin, Yang, Ming, Yun, Yan-Ning, Zhou, Jin-Song, Liu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330453/ https://www.ncbi.nlm.nih.gov/pubmed/35912012 http://dx.doi.org/10.7150/jca.72021

Ejemplares similares

BMI1 promotes osteosarcoma proliferation and metastasis by repressing the transcription of SIK1
por: Wang, Qiang, et al.
Publicado: (2022)

Activation of the LKB1-SIK1 signaling pathway inhibits the TGF-β-mediated epithelial-mesenchymal transition and apoptosis resistance of ovarian carcinoma cells
por: Hong, Bo, et al.
Publicado: (2018)

Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila
por: Choi, Sekyu, et al.
Publicado: (2015)

Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells
por: Yao, Yuan-Hu, et al.
Publicado: (2016)

Loss of the conserved PKA sites of SIK1 and SIK2 increases sleep need
por: Park, Minjeong, et al.
Publicado: (2020)

Dendritic cell–intrinsic LKB1-AMPK/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity
por: vanderZande, Hendrik J.P., et al.
Publicado: (2023)

Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages
por: Darling, Nicola J., et al.
Publicado: (2017)

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma
por: Yang, Sheng-Huei, et al.
Publicado: (2015)

SIK1 suppresses colorectal cancer metastasis and chemoresistance via the TGF-β signaling pathway
por: Gao, Yuan, et al.
Publicado: (2023)

LKB1 deficiency upregulates RELM-α to drive airway goblet cell metaplasia
por: Li, Yu, et al.
Publicado: (2021)

Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer
por: Peng, Jing, et al.
Publicado: (2020)

Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells Via Activation of the LKB1/AMPK Pathway
por: Li, Tingting, et al.
Publicado: (2022)

Phosphorylation of LKB1 by PDK1 Inhibits Cell Proliferation and Organ Growth by Decreased Activation of AMPK
por: Borkowsky, Sarah, et al.
Publicado: (2023)

MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1
por: Huang, Chengzhi, et al.
Publicado: (2019)

LKB1 obliterates Snail stability and inhibits pancreatic cancer metastasis in response to metformin treatment
por: Song, Lele, et al.
Publicado: (2018)

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer
por: Wang, Yinghao, et al.
Publicado: (2017)

DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer
por: Shen, Jiliang, et al.
Publicado: (2017)

The CRTC1-SIK1 Pathway Regulates Entrainment of the Circadian Clock
por: Jagannath, Aarti, et al.
Publicado: (2013)

Salt-Inducible Kinase 1 (SIK1) Is Induced by Gastrin and Inhibits Migration of Gastric Adenocarcinoma Cells
por: Selvik, Linn-Karina M., et al.
Publicado: (2014)

SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK
por: Shi, Xiu, et al.
Publicado: (2022)

Niche-Dependent Regulation of Lkb1 in the Proliferation of Lung Epithelial Progenitor Cells
por: Ma, Qingwen, et al.
Publicado: (2022)

An allosteric regulation mechanism of Arabidopsis Serine/Threonine kinase 1 (SIK1) through phosphorylation
por: Mu, Junxi, et al.
Publicado: (2021)

LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells
por: Tamás, Peter, et al.
Publicado: (2010)

LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014)

Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis
por: Lombardi, Maria Stella, et al.
Publicado: (2017)

PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer
por: Kari, Suresh, et al.
Publicado: (2019)

Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis
por: Huang, Saihua, et al.
Publicado: (2020)

Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis
por: He, Sha-sha, et al.
Publicado: (2017)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis
por: Li, Lin, et al.
Publicado: (2018)

LKB1/STK11 Tumor Suppressor Reduces Angiogenesis by Directly Interacting with VEGFR2 in Tumorigenesis
por: Rho, Seung Bae, et al.
Publicado: (2023)

LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin
por: Jin, Li-Yan, et al.
Publicado: (2020)

Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3
por: Yahara, Yasuhito, et al.
Publicado: (2016)

SIKs control osteocyte responses to parathyroid hormone
por: Wein, Marc N., et al.
Publicado: (2016)

Nuts and bolts of the salt-inducible kinases (SIKs)
por: Darling, Nicola J., et al.
Publicado: (2021)

Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1
por: Zang, Xueyan, et al.
Publicado: (2022)

Arsenic Inhibits Neurite Outgrowth by Inhibiting the LKB1–AMPK Signaling Pathway
por: Wang, Xin, et al.
Publicado: (2010)

Role of SIK1 in the transition of acute kidney injury into chronic kidney disease
por: Hu, Jinxiu, et al.
Publicado: (2021)

Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway
por: Liu, Siwen, et al.
Publicado: (2020)

Down-regulation of salt-inducible kinase 1 (SIK1) is mediated by RNF2 in hepatocarcinogenesis
por: Qu, Chao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rl8ifemtr25f9gbhgsqgqpjujv